Pfizer forecasts 2023 sales of COVID products below estimates
on Tuesday forecast 2023 sales of its COVID-19 products of $21.5 billion that fell short of Wall Street expectations, hit by lower demand in international markets and slower uptake of booster vaccines. The U.S. drugmaker said it expects sales of $13.5 billion from the vaccine for 2023, below…
#pfizerinc #pfizer #manasmishra #bhanvisatija #bengaluru #srirajkalluvila